Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 1211-1219

  Zhu, Wen Fang ^a   Li, Jian ^a   Yu, Li Chao ^a   Wu, Yian ^a   Tang, Xin Ping ^a   Hu, Yi Ming ^a   Chen, Yong Chang ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Circulating tumor cells; EpCAM; MUC1; Non small cell lung cancer; Prognosis; Surgery

Indexed keywords

COMPLEMENTARY DNA; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; MUCIN 1;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD SAMPLING; BRONCHITIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA SYNTHESIS; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUBERCULOUS PLEURISY;

AGED; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCIN-1; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RNA, MESSENGER;

EID: 84899099765     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1162-8     Document Type: Article

References (32)

1. Brundage MD, Devies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer. Chest. 2002;122:1037-57.
2. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancer. J Thorac Oncol. 2008;3:46-52.
3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-43. (Pubitemid 33586866)
4. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol. 2009;6:339-51.
5. Pantel K, Brakenhoff RH, Brandt B.Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329-40. (Pubitemid 351596394)
6. Lu J, Fan T, Zhao Q, et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer. 2010;126:669-83.
7. Ross JS, Slodkowska EA. Circulating and disseminated tumour cells in the management of breast cancer. Am J Clin Pathol. 2009;132:237-45.
8. Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer. 2005;92:906-12. (Pubitemid 40462638)
9. Xenidis N, Ignatiadis M, Apostolaki S, et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol. 2009;27:2177-84.
10. Alix-Panabieres C, Sabine Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Cin Caner Res. 2008;14:5013-21.
11. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer. 2007;96:417-23. (Pubitemid 46215211)
12. Went PTH, Lugli A, Meier S, et al. Frequent EpCAM protein expression in human carcinomas. Hum Pathol. 2004;35:122-8. (Pubitemid 38133932)
13. Went P, Dirnhofer S, Schöpf D, et al. Expression and prognostic significance of EpCAM. J Cancer Mol. 2008;3:169-74. (Pubitemid 351512494)
14. Rao CG, Chianese D, Doyle GV, et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005;27:49-57.
15. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9:874-85.
16. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4:45-60. (Pubitemid 38082153)
17. Nagai S, Takenaka K, Sonobe M, Eiji O, Hiromi W, Fumihiro T. A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer. J Thorac Oncol. 2006;1:46-51. (Pubitemid 47164020)
18. Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Yonezawa S. Combined status of MUC1 mucin and surfactant apoprotein A expression can predict the outcome of patients with small-size lung adenocarcinoma. Histopathology. 2004;44:147-55. (Pubitemid 38296974)
19. Ohgami A, Tsuda T, Osak T, et al. MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. Ann Thorac Surg. 1999;67:810-4. (Pubitemid 29204749)
20. Livak KJ, Schnittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25:402-8. (Pubitemid 34164012)
21. Sergeant G, Penninckx F, Topal B. Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood-a systematic review. J Surg Res. 2008;150:144-52.
22. Xenidis N, Perraki M, Kafousi M, et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol. 2006;24:3756-62. (Pubitemid 46622314)
23. Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res. 2007;13:2992-7. (Pubitemid 46849575)
24. de Albuquerque A, Kubisch L, Stolzel U, et al. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients. J Transl Med. 2012;10:222-8.
25. Tanaka F, Yoneda K, Kondo N, et al. Circulating tumor cell as a diagnotic marker in primary lung cancer. Clin Cancer Res. 2009;15:6980-6.
26. Yamashita J, Matsuo A, Kurusu Y, Saiahoji T, Hayashi N, Ogawa M. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is a independent predictor of survival in nonsmall cell lung cancer: a prospective study. J Thorac Cardiovasc Surg. 2002;124:299-305. (Pubitemid 35025606)
27. Yie S-M, Lou B, Ye S-R, et al. Clinical significance of detecting survivin-expressing circulating cancer cell in patients with non-small cell lung cancer. Lung Cancer. 2009;63:284-90.
28. Yoon SO, Kim YT, Jung KC, Jeon YK, Kim BH, Kim CW. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer. 2011;71:209-16.
29. Fidler IL. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer. 2003;3:453-8.
30. O'Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F. Micrometastases: marker of metastatic potential or evidence or residual disease? Gut. 1997;40:512-5. (Pubitemid 27204932)
31. Fehm T, Becker S, Becker-Pergola G, et al. Presence of apoptotic and nonapotptotic disseminated tumor cells reflects the response to neo-adjuvant systemic therapy in breast cancer. Breast Cancer Res. 2006;8:R60.
32. Zieglschmid V, Hollmann C, Bocher O. Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci. 2005;42:155-96. (Pubitemid 41647727)